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Abstract
The proteasome recognizes its substrates via a diverse set of ubiquitin receptors, including
subunits Rpn10/S5a and Rpn13. In addition, shuttling factors, such as Rad23, recruit substrates to
the proteasome by delivering ubiquitinated proteins. Despite the increasing understanding of the
factors involved in this process, the regulation of substrate delivery remains largely unexplored.
Here we report that Rpn10 is monoubiquitinated in vivo and that this modification has profound
effects on proteasome function. Monoubiquitination regulates the capacity of Rpn10 to interact
with substrates by inhibiting Rpn10’s ubiquitin interacting motif (UIM). We show that Rsp5, a
member of NEDD4 ubiquitin-protein ligase family, and Ubp2, a deubiquitinating enzyme, control
the levels of Rpn10 monoubiquitination in vivo. Notably, monoubiquitination of Rpn10 is
decreased under stress conditions, suggesting a mechanism of control of receptor availability
mediated by the Rsp5-Ubp2 system. Our results reveal an unanticipated link between
monoubiquitination signal and regulation of proteasome function.
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Introduction
A crucial aspect of the ubiquitin-proteasome pathway is the regulation of productive
interaction between polyubiquitinated substrates and the proteasome (Finley, 2009). A
failure of this regulation may lead to proteasome dysfunction and to protein accumulation,
events observed in multiple pathologies (Ciechanover and Brundin, 2003). The proteasome
is composed of a core particle (CP, or 20S particle) and a regulatory particle (RP, 19S, or
PA700; Glickman et al., 1998). The CP is a barrel-shaped complex, which contains multiple
proteolytic active sites facing its interior. The RP recognizes, unfolds and translocates
targeted substrates into the CP. There are several factors involved in the recruitment of
targeted proteins to the RP of the proteasome. Among them, Rpn10/S5a has been shown to
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play a role in binding ubiquitin conjugates by means of a ubiquitin interacting motif (UIM;
Deveraux et al., 1994; Van Nocker et al., 1996; Fu et al., 1998). For example, Rpn10
mediates the targeting to the proteasome of cyclin B1, Sic1, Gic2 and Gcn4 (Verma et al.,
2004; Hanna et al., 2006; Seong et al., 2007). Mutation of RPN10 UIM produces a decrease
in the proteolytic capacity of the proteasome (Elsasser et al., 2004; Verma et al., 2004) and
is lethal in mouse (Hamazaki et al., 2007). Recently, roles of extraproteasomal Rpn10 in
controlling ubiquitin chain synthesis and regulating Dsk2, another ubiquitin receptor, have
been proposed (Matiuhin et al., 2008; Kim et al., 2009; Zhang et al., 2009). Rpn13, another
subunit of the base of the RP which contains a PRU domain, efficiently binds ubiquitin and
promotes the recruitment of ubiquitin conjugates (Husnjak et al., 2008).
Ubiquitin chain recognition by the proteasome also involves UBL-UBA domain proteins
such as Rad23, Ddi1, and Dsk2, which shuttle ubiquitinated substrates to the proteasome.
Proteasomes deficient in Rad23 show a decrease in association of ubiquitin conjugates
(Elsasser et al., 2004) and in protein degradation (Verma et al., 2004). Rad23 functions
exhibit partial redundancy with respect to Rpn10. For instance, RPN10 and RAD23
mutations have additive effects in proteolytic stress phenotypes (Saeki et al., 2002; Elsasser
et al., 2004).
Monoubiquitination is a molecular event different from polyubiquitination that drives the
recruitment of proteins containing ubiquitin binding domains (UBDs). Monoubiquitination
thus provides a signalling mechanism that regulates important cellular pathways such as
DNA repair, histone function and endocytosis (Kirkin and Dikic, 2007). Although multiple
roles of monoubiquitin and polyubiquitin signals in intracellular proteolysis in eukaryotes
have been established, there is no evidence of involvement of monoubiquitin signals in the
regulation of protein degradation by the proteasome.
Here we show that Rpn10 is regulated by monoubiquitination. Monoubiquitination strongly
inhibits the capacity of Rpn10 to interact with substrates, thus decreasing proteasome
activity. We show that Rsp5 and Ubp2 control the levels of Rpn10 monoubiquitination, at
K71, K84 and K99, located within the VWA domain, and in K268, located at the C-terminus
of the protein. We provide genetic evidence that link monoubiquitination of Rpn10 with
proteasome function. In addition, cold shock, heat shock and cadmium reduce Rpn10
monoubiquitination. We propose that Rpn10 monoubiquitination acts as a stress sensitive
mechanism that controls the recruitment of substrates to the proteasome.
Results
Rpn10 is Monoubiquitinated In vivo
In a recent study, it was shown that Rpn10 is degraded by the proteasome and that the
ubiquitin ligase Hul5 is involved in this process (Crosas et al., 2006). To further examine the
physiological significance of ubiquitination of Rpn10 we analyzed the status of Rpn10
protein in exponentially growing cultures. In direct analysis of cell extracts, an additional
Rpn10 inmunoreactive band with slower mobility was observed, suggestive of
postranslational modification by ubiquitin (Figure 1A, b and a). The band was not observed
in cultures from cells carrying a deletion of the RPN10 gene (Figure S1A). We then purified
Rpn10 expressed from an inducible vector (Figure S1B) and from its own chromosomal
locus by means of an integrated C-terminal Tandem Affinity Purification (TAP) tag (Figure
1B). By western blot analysis of purified samples it was observed that Rpn10 showed band
‘a’ again and an additional form (band ‘b’) that suggested modification by two ubiquitin
groups (Figure 1B). Band ‘a’ was analyzed by MS and two unique abundant proteins,
Rpn10 and ubiquitin, were identified (Figure S1C). These approaches were not successful in
detecting polyubiquitinated Rpn10, probably reflecting a relative low abundance of longer
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ubiquitin intermediates of Rpn10. Using a strain that expresses ubiquitin with a 6xHIS N-
terminal tag, pulldown assays of total cell ubiquitin conjugates were performed. With this
approach we observed, in addition to the most abundant form corresponding to
monoubiquitinated Rpn10 (mUb-Rpn10; Figure 1C, lanes 2 to 7), diubiquitinated Rpn10
(lanes 3 to 7) and polyubiquitinated Rpn10 (lanes 6 and 7). Synthesis of polyubiquitined
forms of Rpn10 is catalyzed by the chain elongating factor Hul5, which associates with the
proteasome (Crosas et al., 2006). We performed the same ubiquitin conjugate purification
procedure using a strain that carries a deletion of HUL5 gene. We observed that, in the
absence of Hul5, polyubiquitinated Rpn10 virtually disappeared (Figure 1C, lanes 13 and
14; see also Crosas et al., 2006), but levels of mono and diubiquitinated Rpn10 were not
affected (lanes 9 to 14), suggesting that a Hul5-independent ubiquitin ligating activity is
responsible for Rpn10 mono- and diubiquitination.
Monoubiquitinated Rpn10 is Found in Both Proteasomal And Non-Proteasomal Contexts
Since a significant fraction of cellular Rpn10 is not bound to the proteasome (Fu et al.,
1998; Hiyama et al., 1999; Matiuhin et al., 2008; Kim et al,. 2009; this work) we sought to
determine the cellular context of Rpn10 monoubiquitination. We isolated protein fractions
rich in enzymatic factors of the ubiquitin-proteasome system, in ubiquitin-protein
conjugates, and in Rpn10 (fractions UR8 and UR10; see Figure S2A and supplemental data).
We used fraction UR8 as a catalytically active extract. Incubations of UR8 fraction with
MG132 in the absence of ATP showed that mUb-Rpn10 decreased rapidly whereas,
strikingly, the rest of ubiquitin modified forms of Rpn10 remained constant (Figure 2A,
lanes 1 to 4). These results suggested the involvement of a deubiquitinating enzyme highly
specific for mUb-Rpn10. When the fraction was incubated in the presence of ATP, mUb-
Rpn10 did not decline; instead it remained stable (Figure 2A, lanes 5 to 8), suggesting that
an ATP-dependent activity was counteracting Rpn10 deubiquitination by catalyzing Rpn10
monoubiquitination or by inhibiting deubiquitination. To address this question we added to
the reaction conventionally purified proteasomes, which contain unmodified Rpn10, and we
observed that added proteasomal Rpn10 was robustly monoubiquitinated (Figure 2A, lanes
10 to 13). We performed the same assays shown in Figure 2A but using protein fractions and
proteasomes purified from strains carrying a deletion of the HUL5 gene. Using hul5Δ
samples we observed the same behaviour as with wild-type (Figure 2B). Proteasomes used
in these assays were unable to catalyze Rpn10 monoubiquitination by themselves, but
simply adding fraction UR8, ten fold diluted, reconstituted the reaction efficiently,
indicating a high turnover rate of the Rpn10-ubiquitin ligating activity contained in this
extract (Figure S2B). These findings suggest that levels of mUb-Rpn10 are controlled in
vivo by dynamically opposed ubiquitin ligase and deubiquinating activities, and that
substoichiometric amounts of the ubiquitin ligase bound to the proteasome are sufficient to
promote Rpn10 monoubiquitination.
To corroborate the observation of physiological Rpn10 monoubiquitination we performed a
fractionation of a whole cell extract by Superose 6 chromatography. In this analysis, mUb-
Rpn10 was present both in fractions corresponding to the proteasome elution peak, analyzed
by immunodetection of Rpn12, a component of the lid of the proteasome, and α7, a core
particle subunit (Figure 2C, lanes 16 and 17), and in the non-proteasomal peak of Rpn10
(Figure 2C, lanes 26 and 27). Moreover, proteasomes isolated using Rpn11-Protein A tag
(Leggett et al., 2002), in the presence of ATP and MG132, contained mUb-Rpn10 (Figure
2D). These results provide evidence of in vivo Rpn10 monoubiquitination.
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Rsp5 Ubiquitin Ligase and Ubp2 Deubiquitinating Enzyme Control Rpn10
Monoubiquitination
We searched for enzymatic factors involved in controlling the levels of mUb-Rpn10. Among
likely candidates were ubiquitin ligases that interact with the proteasome, such as Ufd4 and
Ubr1 (Xie and Varshavsky, 2000). We purified proteasomes from ufd4Δ and ubr1Δ strains
and found that the levels of mUb-Rpn10 were identical to those observed in proteasomes
purified from a wild-type strain (Figure S3A), suggesting that neither Ufd4 nor Ubr1 were
ubiquitin ligases for Rpn10.
In addition to a functional interaction with the proteasome, a signature feature of the E3
enzyme that we were searching for might be efficient catalysis of monoubiquitination. An
E3 that fits with this second requirement is Rsp5, orthologue of NEDD4.2 mammalian
enzyme (Dupré et al., 2004), which is involved in many cellular processes in
Saccharomyces cerevisiae and part of a large family of proteins that control analogous
processes in mammalian cells (Hicke, 2001). Rsp5 is founding a complex with the
deubiquitinating enzyme Ubp2, which exhibits antagonistic activity (Kee et al., 2005).
Recently, Rpn10 was a positive hit in a proteomic screen for Rsp5 substrates (Lu et al.,
2008). Therefore, we analyzed the putative involvement of Rsp5 and Ubp2 in Rpn10
monoubiquitination. Wild-type, the rsp5–1 thermosensitive mutant, ubp2Δ, and double
mutant rsp5–1 ubp2Δ strains were used, all of them carrying a GST-Rpn10 expressing
plasmid. Pulled down fractions from cultures grown under galactose induction and
restrictive temperature (see supplemental data and Figure S3B) were analyzed by anti-
Rpn10 western blotting (Figure 3A). Strikingly, the presence of mUb-Rpn10 was completely
dependent on Rsp5 activity (Figure 3A, lanes 6 and 8), suggesting that Rsp5 is the major E3
for Rpn10 in vivo. In addition, levels of mUb-Rpn10 were strongly increased in the absence
of Ubp2 (Figure 3A, lane 7). To corroborate the involvement of Rsp5 in Rpn10
monoubiquitination in vivo, we used a rsp5Δ strain and analyzed the status of endogenous
Rpn10. Cultures of rsp5Δ strains, grown in the presence of 1M sorbitol to rescue growth
(Figure S3C; Kee et al., 2005), showed a strong decrease of endogenous mUb-Rpn10 levels
as compared to a wild-type strain (Figure S3D).
To characterize deubiquitination of proteasomal mUb-Rpn10, we considered, in addition to
Ubp2, the putative activity of Ubp6, which is involved in substrate deubiquitination in the
proteasome and is related to Hul5 (Leggett et al., 2002; Hannah et al., 2006; Crosas et al.,
2006). We performed assays using recombinant Ubp2, Ubp6, the inactive mutant
Ubp6C118A, and proteasome fractions containing mUb-Rpn10, from ubp6Δ strains (Figure
S3E). mUb-Rpn10 was processed by both Ubp2 and Ubp6, but Ubp2 was more efficient in
the reaction (Figure 3B). To observe the effect of Ubp2 and Ubp6 on the levels of
proteasomal mUb-Rpn10 in vivo, cellular extracts from ubp2Δ and ubp6Δ strains were
fractionated by Superose 6 chromatography and the proteasomal peak was analyzed by
western blotting. It was observed that mUb-Rpn10 was significantly increased in
proteasomes from ubp2Δ cells with respect to wild-type proteasomes (Figure 3C). However,
fractions from ubp6Δ cellular extracts showed levels of proteasomal mUb-Rpn10 identical
to the ones of extracts from wild-type cells (Figure 3C). These results suggest a
physiological role of Ubp2, but not of Ubp6, in Rpn10 deubiquitination. Therefore, our data
suggest that the catalytic cycle that controls homeostasis of mUb-Rpn10 is largely
independent of ubiquitin chain processing by Hul5 and Ubp6 in the proteasome.
Monoubiquitination of Rpn10 In vitro
To establish the direct involvement of Rsp5 in the catalysis of Rpn10 monoubiquitination
we attempted to reconstitute the enzymatic reaction in vitro. Incubations of free or
proteasomal Rpn10 with recombinant E1, Ubc4, Rsp5 and 6xHIS-ubiquitin showed that
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catalysis was promoted only in the presence of Rsp5, excluding an E3-independent
monoubiquitination (Hoeller et al., 2007), and that monoubiquitination was efficiently
promoted for both free and proteasomal Rpn10 (Figure 4A and 4B, left panel). A remarkable
feature of these reactions is that they are highly specific in producing mUb-Rpn10, and only
synthesis of Rpn10-Ub2 was observed secondarily (Figure 4A, long exposure). These results
recapitulate the observations of Rpn10 monoubiquitination with endogenous extracts (Figure
2A and 2B) and in hul5Δ samples in vivo (Figure 1C), suggesting that the reaction in vitro
largely reproduces the physiological conditions.
Rpn10 UIM is Required for Rpn10 Monoubiquitination
The NEDD4 ubiquitin-protein ligase family detects substrates and protein adaptors that
contain PPY or UIM motifs (Polo et al., 2002; Hicke and Dunn, 2003; Dupré et al., 2004;
Hoeller et al., 2006). The latter type of protein-protein interaction usually requires a
functional UIM and promotes the so-called ‘coupled’ monoubiquitination (Hoeller et al.,
2006). Since Rpn10 is a UIM protein, we assessed whether this motif is required for
monoubiquitination. We purified proteasomes from a strain that carries the Rpn10UIM
mutant (Elsasser et al., 2004) and performed Rpn10 monoubiquitination reactions. We
observed a dramatic inhibition of the synthesis of mUb-Rpn10 in Rpn10UIM proteasomes,
with respect to wild-type proteasomes (Figure 4B). In addition, when the activity of cell
fraction UR8 towards wild-type and Rpn10UIM proteasomes was challenged, it was observed
again that monoubiquitination was not promoted in the Rpn10UIM mutant (Figure 4C). These
results show that the UIM is necessary for Rpn10 monoubiquitination.
Monoubiquitination Takes Place in Distinct Lysines of Rpn10 and is Required to Rescue
Proteasome Function
We scaled up the in vitro reaction of Rpn10 monoubiquitination in order to produce higher
amounts of mUb-Rpn10 for MS analysis. In optimized reactions, large amounts of mono and
diubiquitinated forms of Rpn10 were produced, including tri- and tetraubiquitinated Rpn10
at lower levels, but no polyubiquitinated Rpn10 (Figure 4D). However, with this assay we
could not distinguish the topology of the ubiquitin linkage formed because multi-
monoubiquitination and short ubiquitin chains produce a similar electrophoretic mobility
shift. To address this important issue we performed the reaction using methylated ubiquitin,
which cannot form Ub chains (Hershko and Heller, 1985). Strikingly, this reaction (Figure
4E) produced the same pattern of ubiquitination observed using wild-type ubiquitin (Figure
4D), including four bands of Rpn10 modification, which is similar to the pattern observed in
purified endogenous ubiquitinated Rpn10 (Figure 1C, lane 14; se also Crosas et al., 2006).
In addition, a notable observation is that Rsp5, although inactive in the synthesis of
polyubiquitinated forms of Rpn10, undergoes auto-polyubiquitination (Figure 4F), likely
generating K63-linked ubiquitin chains (Saeki et al., 2009). These results suggest that
Rpn10 is multi-monoubiquitinated at four distinct lysine residues. To detect the residues
modified by ubiquitin in this reaction, the two major produced bands corresponding to
Rpn10-Ub1 and Rpn10-Ub2 (Figure S4A) were excised from the gel and analyzed by LC-
MS/MS. The analysis revealed that monoubiquitination could engage K71, K84, K99 and
K268 (Figure 5A and Figure S4B). K71, K84, and K99 are located within the VWA domain,
whereas K268 is situated at the very C-terminus of the protein. In Rpn10-Ub2 band only
modifications at K84 and K268 were identified and, in the whole analysis, K84 was the most
abundantly modified, representing the 52% of the GlyGly-containing peptides (Figure 5A).
To further characterize Rpn10 modification, lysine residues of Rpn10 were mutated (see
supplemental data). In GST pulldowns, forms involving Rpn10K84R mutation showed a
strong decrease in monoubiquitination (Figure 5B, lanes 4, 7 and 8), while mutations in
other lysines produced only mild or undetectable effects (Figure 5B). Nonetheless, our
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results show that additional lysines may be modified. Thus, to analyze Rpn10 forms
defective in ubiquitination we prepared Rpn10K71,84,99,268R and Rpn10NO–K mutants, and
the control mutant Rpn10K104,130,133,134R. Analysis of GST pulldowns of these forms
showed that the Rpn10K104,130,133,134R mutant exhibited monoubiquitination to wild-type
levels (Figure 5C, lanes 1 and 4), whereas Rpn10K71,84,99,268R (lane 3) and Rpn10NO–K (lane
2) mutants showed very low levels of modification. In a parallel assay, Rpn10K84R mutant
showed a decrease in monoubiquitination (lane 5) similar to that observed in the
Rpn10K71,84,99,268R mutant. K84 monoubiquitination was also analyzed with the
Rpn10K84only mutant, in which we mutated all lysine residues to arginine except for K84.
This form was expressed in yeast and showed monoubiquitination nearly to physiological
levels (Figure 5D), suggesting a dominant role of K84 in the process of Rpn10
monoubiquitination. We performed reactions in vitro using recombinant Rpn10K84only as a
substrate. We observed that, while methylated ubiquitin produced one band of
monoubiquitination, wild-type ubiquitin produced several bands (Figure 5E), suggesting
that, secondarily (see Figures 4D and E), Rsp5 is able to build short ubiquitin chains, maybe
due to the absence of additional lysine residues in the mutant Rpn10 sequence.
To assess the functional relevance of Rpn10 monoubiquitination, a complementation test
was performed. Strains carrying a double deletion of RPN10 and RAD23 genes are strongly
deficient in recruiting substrates to the proteasome and exhibit slow growth (Figure S4C;
Chen and Madura, 2002). We tested the capacity of plasmid-borne Rpn10 to rescue the
absence of the RPN10 gene. We observed that wild-type form of Rpn10 efficiently rescued
growth of a rpn10Δrad23Δ strain (Figure 5F). Similarly, the rpn10K104,130,133,134R mutant,
which shows monoubiquitination at wild-type levels, fully complemented Rpn10 function.
However, the rpn10K71,84,99,268R and the rpn10NO–K mutants, which show impaired
monoubiquitination, did not rescue Rpn10 function to WT levels (Figure 5F). To our
knowledge, this is the first genetic evidence linking proteasome function with
monoubiquitination of a protein.
Monoubiquitinated Rpn10 Shows Low Affinity to Ubiquitin Conjugates
We asked what was the role of monoubiquitination in the context of proteasome function.
The UIM of Rpn10 is involved in the recruitment of substrates to the proteasome (Fu et al.,
1998; Elsasser et al., 2004, Verma et al., 2004). The interaction between ubiquitin and
Rpn10 UIM relies on a hydrophobic patch on the surface of ubiquitin, composed of Leucine
8, Isoleucine 44, and Valine 70, which define a pocket for the methyl group of a strictly
conserved alanine within the UIM, alanine 231 in the case of Rpn10 (Wang et al., 2005).
We tested whether in mUb-Rpn10, the covalently linked ubiquitin group could impose a
functional restriction to Rpn10 UIM by means of a ‘fold-back’ interaction (Di Fiore, 2003;
Woelk et al., 2006). We obtained a cellular fraction containing 6xHIS tagged polyubiquitin
conjugates (see supplemental data and Figure S5A, lane 10) and immobilized it to Ni-NTA
resin (Figure 6A, lane 1). The binding capacity of Rpn10 and mUb-Rpn10 (synthesized in
vitro, as in Figure 4A) to immobilized conjugates was challenged. We observed that
unmodified Rpn10 could bind very efficiently to conjugates, but mUb-Rpn10 did not
(Figure 6A, lanes 5 and 6), suggesting that monoubiquitination of Rpn10 inhibits the activity
of the UIMs. In the conditions of the binding assay no Rpn10 deubiquitination was observed
(Figure S5B). To further characterize this interaction, we generated permanently
monoubiquitinated forms by appending a ubiquitin group to Rpn10. We included the Rpn10-
UbI44A mutant, which shows a decreased affinity of linked ubiquitin to the UIM (Hoeller et
al., 2006). Thus, different forms were expressed and bound to GSH-beads (Figure 6B, lanes
1–4) and their affinity to the cellular fraction of polyubiquitin-conjugates, as the liquid
phase, was tested (lane 5). As in previous assay, conjugates bound strongly to Rpn10 (lane
7) but not to Rpn10 linked to Ub (lane 8). Interestingly, the Rpn10-UbI44A mutant partially
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re-established the capacity of Rpn10 to bind conjugates, showing that the non-covalent
ubiquitin-UIM interaction is involved in the inhibition of the UIM.
In the previous assay we used polyubiquitin conjugates isolated from cells, therefore we
could not exclude the interference of cellular factors associated to ubiquitin conjugates in the
binding assay. Thus, we challenged the affinity of Rpn10 and Rpn10 modified forms
towards pure unanchored polyubiquitin chains (see supplemental data). In this assay the
Rpn10K84only mutant was included to observe the behaviour of Rpn10 modified uniquely at
K84. Again, binding assays showed that immobilized polyubiquitin chains (Figure 6C, lane
1) bound efficiently to unmodified Rpn10 (wild-type and Rpn10K84only mutant) but not their
respective monoubiquitinated forms (Figure 6C, lanes 3–8). We also tested the affinity of
the Rpn10-Ub fusion towards unanchored polyubiquitin chains. Consistently with the assay
using cellular polyubiquitin conjugates (Figure 6B), Rpn10-Ub did not bind to ubiquitin
chains (Figure 6C, lanes 9–10), whereas the Rpn10-UbI44A mutant partially re-established
binding (lanes 11–12). Therefore, mUb-Rpn10 synthesized by Rsp5 and the Rpn10-Ub
chimera exhibit the same feature: a dramatic decrease in their affinity to ligands, suggesting
that Rpn10-Ub fusion is a good approach to study the effect of monoubiquitination in Rpn10
UIM function. Moreover, the partial rescue of polyubiquitin binding capacity of the Rpn10-
UbI44A mutant showed that the decreased affinity to polyubiquitin is due to an
intramolecular UIM-monoubiquitin hydrophobic interaction.
According to the presented data, the interaction UIM-ubiquitin appears to be essential for
both catalysis (Figure 4B and C) and function (Figure 6A–C) of Rpn10 monoubiquitination.
The capacity of ubiquitinI44A to promote Rpn10 monoubiquitination was tested in vitro and
very poor activity was observed, as compared to the reaction using wild-type ubiquitin
(Figure 6D). These results complement the data obtained using Rpn10UIM mutant (Figure
4B), and, altogether, show that Rsp5 requires the Rpn10 UIM-ubiquitin hydrophobic
interaction to be active.
Monoubiquitination of Rpn10 Reduces the Proteolytic Activity of the Proteasome
In Figures 6A–C we show that mUb-Rpn10 exhibits low affinity to polyubiquitin and
polyubiquitinated substrates but we do not show the effect in active proteasomes. To address
this question, we performed cyclin B degradation tests in a time course fashion, using
equimolar amounts of Rpn10 and Rpn10-Ub forms added to rpn10Δ proteasomes (Figure
S5C). We observed that degradation rates of cyclin B were strongly accelerated when Rpn10
was added, slightly accelerated when Rpn10-UbI44A was added, and substantially inhibited
in absence of Rpn10 or adding Rpn10-Ub (Figure 6E). However, these results could also be
explained by a decreased proteasome interaction of the Rpn10-Ub form. To rule out this
possibility, we compared the affinity of Rpn10, Rpn10-Ub and Rpn10-UbI44A to rpn10Δ
proteasomes by binding assays, and observed that all Rpn10 forms bound identically to the
proteasome (Figure 6F), showing that degradation of cyclin B is promoted by a proteasome-
bound Rpn10.
If mUb- Rpn10 shows an inactive UIM, one could expect a strong decrease of functional
complementation in vivo of Rpn10-Ub compared to wild-type Rpn10, and an intermediate
complementation of Rpn10-UbI44A (see Figures 6B, C and E). To check this hypothesis, we
expressed these proteins in rpn10Δ rad23Δ cells. We observed that Rpn10-Ub could not
complement rpn10 null mutants efficiently, showing the strong effect of permanent
monoubiquitination in Rpn10 (Figure 6G). This effect was dependent on the UIM-ubiquitin
interaction of Rpn10-Ub, because the rpn10-UbI44A mutation, consistently with binding
assays, partially re-established complementation (Figure 6G). The levels of expression of
plasmid-borne RPN10 variants were similar to that of endogenous Rpn10 in all cases (Figure
S5D).
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Rpn10 Monoubiquitination is Reduced Under Conditions of Proteolytic Stress
Our observations suggested that monoubiquitination of Rpn10 could regulate the capacity of
this substrate receptor to bind ubiquitinated substrates. We asked whether the levels of mUb-
Rpn10 could be influenced by conditions that require functional Rpn10, such as proteolytic
stress (Medicherla et al., 2008). We analyzed the status of Rpn10 in cultures growing at 14,
28 or 37 °C (Figure 7A, B, F and G). We observed that Rpn10 monoubiquitination was
strongly decreased in cells subjected to either cold or heat shock. We asked whether a
similar response to stress could also be observed at 28 °C in the presence of cadmium, a
compound that promotes proteolytic stress (Jungmann et al., 1993; Medicherla et al., 2008).
We observed that, in the presence of cadmium, Rpn10 monoubiquitination was not induced
(Figure 7C). We then asked whether the tight control of mUb-Rpn10 levels was a specific
response to proteolytic stress or could be promoted by other kind of perturbations. To
address this question we supplemented cultures with ethyl methyl sulfoxide (EMS) to cause
DNA damage, or NaCl to induce osmotic stress in the same manner than in previous assays.
We observed that Rpn10 monoubiquitination persisted under these conditions (Figure 7D
and E), showing a specific correlation of elevated protein degradation with low levels of
mUb-Rpn10.
Discussion
Monoubiquitination Of A Polyubiquitin Receptor
Monoubiquitination is conserved from yeast to mammals and involved in important cellular
processes such as endocytosis and regulation of nuclear functions (Hicke, 2001; Dupré et
al., 2004; Kirkin and Dikic, 2007). Monoubiquitinated proteins are usually recognized by
specific receptors that contain UBDs. For example, in the endocytic pathway, Vps9, Sts1,
Sts2, Eps15 or Hrs are UBD-containing protein adaptors that trigger protein internalization
by binding to monoubiquitinated cargo. In addition, these factors are all monoubiquitinated
in vivo (Di Fiore et al., 2003; Hicke and Dunn, 2003; Hoeller et al., 2006; Woelk et al.,
2006). In the context of the proteasome, Rpn10 binds polyubiquitinated substrates by means
of one or two UIMs (Van Nocker et al., 1996; Elsasser et al., 2004; Verma et al., 2004;
Wang et al., 2005). In this work we show that Rpn10 is regulated by ‘coupled’
monoubiquitination, constituting to our knowledge the first link between regulation of
proteasome function and monoubiquitin signal. In vivo, Rpn10 shows multi-
monoubiquitination and polyubiquitination. The formation of polyubiquitinated forms of
Rpn10 depends on the presence of the ubiquitin chain elongating factor, Hul5, and correlates
with Rpn10 turnover (Crosas et al., 2006). We could uncouple Rpn10 monoubiquitination
from polyubiquitination by deleting the HUL5 gene. Moreover, in vivo levels of mUb-
Rpn10 are not affected in ubp6Δ cells, suggesting that the machinery involved in the process
of Rpn10 monoubiquitination is essentially independent of ubiquitin chain formation and
remodeling.
Rsp5/Nedd4-like Ubiquitin-Protein Ligase and Ubp2 Deubiquitinating Enzyme Regulate
Rpn10 Monoubiquitination
The ubiquitin-protein ligase involved in Rpn10 monoubiquitination is Rsp5, a member of
the Nedd4 HECT ligase family. Rsp5 and its mammalian orthologue Nedd4.2 have emerged
as multitasking enzymes with conserved functions, being involved in endocytosis and
nuclear roles (Hicke and Dunn, 2003; Kirkin and Dikic, 2007). It has been proposed that
Rsp5-Ubp2 association provides a mechanism of monoubiquitination based on the capacity
of Ubp2 to disassemble K63 ubiquitin chains synthesized by Rsp5 (Kee et al., 2006). Our
data shows that Rsp5 and Ubp2 exert opposed driving forces in the control of mUb-Rpn10
homeostasis in vivo, however, Rsp5 is sufficient for the production of mUb-Rpn10. Ubp2 is
highly active towards Rpn10-monoubiquitin isopeptide bonds and exerts a homeostatic
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control of mUb-Rpn10 (Figure 2A, 2B and 3A). It should be noted that, in the absence of
Ubp2, a significant fraction of Rpn10 remains unmodified suggesting that other DUBs may
be involved in deubiquitination of mUb-Rpn10 in vivo.
We have reconstituted the reaction of Rpn10 monoubiquitination using recombinant proteins
and observed that monoubiquitination can be efficiently catalyzed with either wild-type or
methylated ubiquitin, showing a pattern of multi-monoubiquitination. MS analysis
confirmed modification at four distinct lysine residues: preferentially to K84, placed within
the VWA domain, and to K268, in the C-terminus of the sequence, and secondarily to K71
and K99.
Monoubiquitination, a Mechanism Controlling Substrate-Proteasome Interaction and
Proteasome Catalytic Rates
We have found that the UIM-ubiquitin interaction is essential in the monoubiquitination
reaction, since mutations at Rpn10 UIM or at ubiquitin I44 abrogate catalysis (Figures 4 and
6). This feature usually implies that the reaction product establishes an intramolecular
interaction between the UIM and the linked monoubiquitin moiety, thus impairing further
ubiquitination events and favoring monoubiquitination rather than polyubiquitination (Di
Fiore, 2003; Woelk et al., 2006). Indeed, our data supports that Rpn10 and mUb-Rpn10 are
two functionally distinct molecules: mUb-Rpn10 has lost the capacity exhibited by
unmodified Rpn10 to bind ubiquitin conjugates or unanchored polyubiquitin chains (Figure
6). This impairment is due to a UIM-ubiquitin interaction in cis, because the RPN10-UbI44A
mutant partially recovers the capacity to bind polyubiquitin. In addition, Rpn10 linked to
monoubiquitin imposes a dramatic inhibition of cyclin B degradation, and in the cell,
impairs full rescue of Rpn10 function, but simply restoring the UIM availability with the
Rpn10-UbI44A mutant results in a strong rescue of Rpn10 function (Figure 6). An additional
aspect that should be considered is the putative effect of K84 monoubiquitination, not only
on UIM, but also on the VWA domain, involved in protein degradation in a UIM-
independent manner (Verma et al., 2004). The fact that K84 is located within the VWA
domain suggests that this domain could be affected by K84 monoubiquitination. An
interesting hypothesis is that modifications at K268 and at K84 inhibit protein degradation
with different efficiency.
With these observations, it could be predicted that when mUb-Rpn10 levels are increased in
the cell, protein targeting and degradation to the proteasome would be decreased. Cells
carrying a deletion of the UBP2 gene show substantial stabilization of proteasomal mUb-
Rpn10 (Figure 3C), and consistently, these cells accumulate K48 ubiquitin linkages, as
established in a recent study (Xu et al., 2009). This result would not be expected considering
only the activity of Ubp2 on K63 ubiquitin chains (Kee et al., 2006). However, the
accumulation of K48 chains fits in our model of attenuated proteasomal activity when mUb-
Rpn10 levels are increased due to deletion of UBP2. The relative low abundance mUb-
Rpn10 in growing cultures at standard conditions could be explained by the importance of
the homeostasis of proteasome activity in the cell. Indeed, high levels of Rpn10-Ub cause a
strong phenotype (Figure 6G). An additional explanation could be that Rpn10 is targeted for
monoubiquitination only in a subpopulation of proteasomes, but further work is required to
test this hypothesis.
We have observed that mUb-Rpn10 is dramatically decreased in cultures grown at low and
high temperatures, and in the presence of cadmium. According to our results, suppression of
Rpn10 monoubiquitination would increase the availability of Rpn10 UIM, promoting
activation of this ubiquitin receptor. Rpn10 is essential for the degradation of damaged
newly synthesized proteins, which are strongly increased at low and high temperatures and
in the presence of cadmium (Medicherla et al., 2008), and in this scenario, Rpn10 function
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requires an active UIM (Elsasser et al., 2004; Verma et al., 2004). We have observed that
Rpn10 monoubiquitination is dramatically decreased in these conditions, suggesting a
mechanism to increase the availability of Rpn10 UIM.
Regulation of the Proteasome by Associated Ubiquitin Conjugating and Deconjugating
Activities
Rsp5-dependent monoubiquitination of Rpn10, by impairing substrate binding, constitutes
an efficient control of proteasome activity. In absence of monoubiquitination, substrate
recognition by Rpn10 would promote the engagement of proteasomal ubiquitin hydrolases,
such as Ubp6/Usp14 or Rpn11, and chain elongating factor Hul5 (Yao and Cohen, 2002;
Verma et al., 2004; Crosas, et al., 2006; Hanna et al., 2006), which define a second level of
proteasome regulation. Thus, two evolutionarily conserved ubiquitin ligases, Hul5/KIAA10
and Rsp5/Nedd4.2, and their related deubiquitinating enzymes, Ubp6/Usp14 and Ubp2,
respectively, regulate early steps of proteasomal mediated degradation, underscoring the
relevance of associated enzymatic factors in proteasome function. It has been recently
published that p54, the Drosophila orthologue of Rpn10, is modified by up to four ubiquitin
groups in vivo (Lipinszki et al., 2009), resembling multiple monoubiquitination of yeast
Rpn10, characterized herein. Further work will be required to establish the physiological
role of Rpn10 monoubiquitination in higher eukariotes.
Methods
Yeast methods, proteasome purification, ubiquitin conjugating and deconjugating reactions
and binding assays are described elsewhere (Rose et al., 1990; Leggett et al., 2002; Crosas
et al., 2006; Lu et al; 2008) or in the supplemental data. Cloning, expression and purification
of the proteins are described in the supplemental data. In mass spectrometry analysis,
ubiquitination sites were identified by excising gel bands containing Rpn10 and in-gel
digested with trypsin. Peptide were separated by nanoscale reversed phase liquid
chromatography coupled to hybrid tandem mass spectrometer (LTQ Orbitrap;
ThermoElectron). MS/MS spectra were matched to Rpn10 sequence using sequest algorithm
(Yates et al., 1995) with a mass increment of 114.0429 (signature diglycine generated by
trypsin digest of conjugated ubiquitin) on lysine residues.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Rpn10 is monoubiquitinated in vivo
(A) Logarithmically growing wild-type yeast cells (see strain list in Table S1) analyzed by
western blotting using Rpn10 antibody. Time points were taken as shown.
(B) Purified TAP-tagged Rpn10, analyzed by western blotting. Increasing amounts of
fractions were visualized by short (left) and long film exposures. Bands ‘a’ and ‘b’ represent
putative mono and diubiquitinated Rpn10. Asterisk, Rpn10 breakdown product.
(C) Native 6xHis-Ubiquitin conjugates eluted at different imidazole concentrations (lanes 1
to 7), analyzed by western blotting with Rpn10 antibody. The same purification and analysis
procedure was performed using a hul5Δ strain (lanes 8 to 14). Immunoblots with antibodies
against proteasome subunits Rpt1, α7 and Rpn12 are included. Asterisks, unspecific bands
detected with Rpn10 antibody.
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Figure 2. Monoubiquitination of proteasomal Rpn10 is dynamically regulated
(A–B) Fraction UR8 (see supplemental data and Figure S2A) was incubated without ATP
(lanes 1 to 4), with 5mM ATP (lanes 5 to 8) or with 5 mM ATP and purified proteasomes
(lanes 10 to 13), at 30 °C, and time points were taken. In B, assays were performed using
UR8 fraction and proteasomes from hul5Δ strains.
(C) Total cell lysates from a wild-type strain were applied to a Superose 6 column. Fractions
obtained were analyzed by western blotting of Rpn10, Rpn12 or α7 proteasome components.
(D) Proteasomes purified in the presence of 5 mM ATP and 5 μM of MG132 were analyzed
by two dimensioned electrophoresis (isoelectrofocusing and 4–12% gradient SDS-PAGE)
followed by Rpn10 immunodetection. Asterisk, Rpn10 breakdown product.
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Figure 3. Levels of monoubiquitinated Rpn10 are controlled by Rsp5-Ubp2 enzymatic system in
vivo
(A) Wild-type, rsp5-1, ubp2Δ and double rsp5-1 ubp2Δ strains, carrying GST-Rpn10
galactose inducible plasmid (plasmids are listed in Table S2), were expressed and shifted to
restrictive temperature. GST-Rpn10 was pulled down and analyzed by Rpn10 western
blotting. Lanes 1 to 4, cultures grown at 28 °C. Lanes 5 to 8, cultures grown at 35 °C.
Induction levels are shown in Figure S3B.
(B) Monoubiquitinated Rpn10 from a ubp6Δ strain (see Figure S3E and supplemental data)
was incubated with equimolar amounts of Ubp2, Ubp6 and Ubp6C118A. Reactions were
analyzed by Rpn10 western blotting.
(C) Total cell lysates from wild-type, ubp2Δ and ubp6Δ strains were applied to a Superose 6
chromatography. Fractions that contain eluted proteasome were analyzed by Rpn10 western
blotting.
Isasa et al. Page 15
Mol Cell. Author manuscript; available in PMC 2012 February 19.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 4. Reconstitution of the reaction of Rpn10 monoubiquitination in vitro
(A) Recombinant Rsp5, Rpn10, E1, Ubc4 and ubiquitin were incubated as indicated. Right
lanes show a reaction in which Rpn10 input was doubled. Lower panel, longer exposures
which show diubiquitinated Rpn10 (Rpn10-Ub2) more clearly.
(B) Proteasomes (wild-type and Rpn10UIM) were incubated with Rsp5, E1, Ubc4 and
ubiquitin.
(C) Proteasomes (wild-type and Rpn10UIM) were incubated with a cell lysate fraction. An
inhibitory effect of o-phenanthroline was observed when 1 mM final concentration of this
compound was added to the reaction. Asterisk, Rpn10 breakdown product.
(D–E) Scaled-up reactions of Rpn10 monoubiquitination in vitro, using wild-type (D) or
methylated ubiquitin (E). Asterisk, unspecific band also observed in 4A.
(F) Autoubiquitinated Rsp5 using wild-type or methylated ubiquitin, from reactions similar
to (D) and (E), respectively.
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Figure 5. Analysis of Rpn10 lysines modified by ubiquitin
(A) Summary of mass spectrometry analysis of Rpn10. Left, relative abundance of the Gly-
Gly peptides found. Right, scheme of Rpn10 protein including all lysines contained in the
sequence. Modified lysines are shown in bold.
(B–D) GST-Rpn10 K to R mutants including all Rpn10 lysines (oligos are listed in Table
S3) were expressed under galactose induction. Pulled down GST-Rpn10 forms were
analyzed by Rpn10 western blotting.
(E) Monoubiquitination reactions of Rpn10K84only mutant using wild-type and methylated
ubiquitin. Asterisk, electrophoretic artifact shown by the mutant, observed also in non-
incubated samples. Short and long exposures of the film are shown.
(F) Ability of a set of Rpn10 mutants to rescue growth defect exhibited by rpn10Δrad23Δ
yeast strain (see supplemental data). Rpn10 forms were expressed at 22 °C using a galactose
inducible vector, selected with a URA3 marker. Cells (3×104) were spotted in the first
column and 3/7 serial dilutions were made for the successive columns.
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Figure 6. Monoubiquitinated Rpn10 shows an inactive UIM and decreases the proteolytic
activity of the proteasome
(A) Binding assay of Rpn10 and mUb-Rpn10 to a fraction of endogenous HIS-ubiquitin
conjugates (see Figure S5A and supplemental data) immobilized on Ni-NTA beads (lane 1).
Liquid phase inputs include unmodified Rpn10, as a control (lane 3), and a
monoubiquitination reaction sample (mUb reaction), which contains both unmodified Rpn10
and mUb-Rpn10 (Rpn10-Ub1) (lane 4). Bound material is shown in lanes 5 and 6.
(B) Binding assay of Rpn10 and C-terminal ubiquitin fusions (Rpn10-Ub and Rpn10-
UbI44A), immobilized in beads (lanes 1 to 4), to a fraction of endogenous HIS-ubiquitin
conjugates (input, lane 5). Bound material was eluted and analyzed by HIS western blotting
(lanes 6 to 9).
(C) Binding assay of unmodified and mUb-Rpn10 (wild-type and K84only mutant), Rpn10-
Ub and Rpn10-UbI44A to unanchored polyubiquitin chains immobilized in beads (lane 1).
Input and bound material are shown for each sample (lanes 3 to 12). A control of Rpn10
binding to empty beads is included in lane 2. A longer film exposure is shown for lanes 5 to
8.
(D) Reaction of Rpn10 monoubiquitination in vitro using wild-type ubiquitin and I44A
mutant.
(E) Time-course degradation assays in vitro with proteasomes deficient in Rpn10, equimolar
amounts of Rpn10 forms and ubiquitinated cyclin B. Points at indicated times were taken
and analyzed by anti cyclin B, Rpn10 and Rpn12 western blotting.
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(F) Rpn10-Ub binding to rpn10Δ proteasomes. GST-Rpn10, GST-Rpn10-Ub and GST-
Rpn10-UbI44A were immobilized to beads and proteasomes were applied as the soluble
phase.
(G) Rescue of Rpn10 function by Rpn10-Ub forms, including Rpn10, Rpn10-Ub and
Rpn10-UbI44A expressed from a vector. The assay was performed as in figure 5F. Levels of
protein expression are shown in Figure S5D.
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Figure 7. Monoubiquitination of Rpn10 is decreased under certain stress conditions
(A–G) Yeast cells (wild-type, rad23Δ and ubp2Δ) were grown in YPD liquid media at the
described conditions. Cadmium: 200 μM, Ethyl methyl sulfoxide (EMS): 0.08%, NaCl: 500
mM. Samples were taken at indicated times, number of cells normalized and analyzed by
western blotting with Rpn10 antibody.
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